LOS ANGELES--(BUSINESS WIRE)--HemaCare Corporation (OTCBB:HEMA) announced today that the Company generated third quarter revenue of $7.3 million and a net loss of $621,000, or $0.06/share, compared to third quarter 2009 revenue of $8.4 million and net income of $233,000, or $0.02/share. The three month loss included $321,000 in expenses related to the closure of an unprofitable facility in Maine and the write off of impaired assets. The Company generated $23.2 million of revenue for the first nine months of 2010, with a net loss of $601,000 or $0.06/share, compared to $28.1 million in revenue for the same period in 2009, with $660,000 in net income or $0.07/share. The nine month 2010 net loss included $321,000 in expenses related to the closure of an unprofitable facility in Maine, the write off of impaired assets, and $184,000 in severance expenses paid to the Company’s former Chief Executive Officer and Chief Financial Officer in the first quarter.
